Rhagolwg
My research focuses on the design, synthesis and biological evaluation of novel therapeutic and diagnostic agents across infectious diseases, oncology and neurodegeneration. I have extensive expertise in synthetic organic chemistry, medicinal chemistry, natural product鈥搃nspired drug discovery, and structure鈥揳ctivity relationship (SAR) development. My work spans the synthesis of new antibiotics, antituberculosis agents, kinase inhibitors for triple鈥憂egative breast cancer, antitrypanosomal compounds for Chagas disease, and antiviral candidates targeting CHIKV. I also develop next鈥慻eneration diagnostic tools for neurodegenerative diseases through chemical antibody technologies in collaboration with leading UK and international partners.
Cymwysterau
- BSc: Pharmaceutical Sciences
Aleppo University, - Profesiynol: United Kingdom
Higher Education Academy, - MSc: Medicinal Chemistry
University of Paris-Sud, - PhD: University of Paris Sud
University of Paris-Sud,
Addysgu ac Arolygiaeth
She is proud to hold a Fellowship with the UK Higher Education Academy (FHEA), a recognition of her dedication to high-quality teaching and learning. This accreditation has shaped her approach to curriculum design, assessment strategies, small-group teaching, and undergraduate research supervision. She has extensive experience in developing and delivering innovative MPharm and MSc programs, with a strong emphasis on inclusive education, study skills enhancement, and career development support for both domestic and international students. At 精东传媒, she teaches chemistry in the Mpharm program (MSE-0012, MSE-1033-MSE-1034, MSE-1036 and MSE-0013), leads module MSE-0013, and serves as the Foundation Year Lead.
Hadia is currently supervising undergraduate research projects and welcomes undergraduate students to apply.
Diddordebau Ymchwil
Hadia is leading the research in Medicinal Chemistry at 精东传媒, her research focuses on the design, synthesis and biological evaluation of novel therapeutic and diagnostic agents across infectious diseases, oncology and neurodegeneration. She has extensive expertise in synthetic organic chemistry, medicinal chemistry, natural product鈥搃nspired drug discovery, and structure鈥揳ctivity relationship (SAR) development. Her work spans the synthesis of new antibiotics, antituberculosis agents, kinase inhibitors for triple鈥憂egative breast cancer, antitrypanosomal compounds for Chagas disease, and antiviral candidates targeting CHIKV. She also develop next鈥慻eneration diagnostic tools for neurodegenerative diseases through chemical antibody technologies in collaboration with leading UK and international partners.
Cyfleoedd Project 脭l-radd
1- Design and synthesis of new anticancer drugs
2- Design and synthesis of neurodegenerative diseases treatment
3- Design and synthesis of new antivirals
In addition to working on high quality research projects in Hadia鈥� s Research group, you will gain a strong set of skills and experiences that significantly enhance their academic and professional development. This includes:
鈥� Hands on experimental training in both chemistry and biology
鈥� Practical experience in molecular design, from analysing protein structures to designing ligands with improved binding and selectivity
鈥� Exposure to real drug discovery workflows, moving from conceptual design to synthesis, biological testing, and data interpretation
鈥� Opportunities to connect theoretical knowledge with real therapeutic challenges, strengthening scientific reasoning and problem solving
鈥� The chance to contribute to high quality, publishable research, building a strong academic profile
鈥� A solid foundation for future PhD or postdoctoral applications, as well as careers in the pharmaceutical industry, biotechnology, or research laboratories
Students in this group don鈥檛 just learn techniques, they develop the mindset and skillset of modern drug discovery scientists.
Cyhoeddiadau
2026
- Cyhoeddwyd
Elsayed, Z. M., Tawfik, H. O., Hemeda, L. R., Nafie, M. S., Almahli, H., Monir, R., Sindi, I. A., Elkaeed, E. B., Elbadawi, M. M., El Hassab, M. A. & Eldehna, W. M., Mai 2026, Yn: RSC Medicinal Chemistry. 17, 6, t. 2984-3002 19 t.
Allbwn ymchwil: Cyfraniad at gyfnodolyn 鈥� Erthygl 鈥� adolygiad gan gymheiriaid - E-gyhoeddi cyn argraffu
Almahli, H., Treble-Smith , C. & Gardner, E., 23 Medi 2026, (E-gyhoeddi cyn argraffu) Disease-Oriented Drug Repurposing Strategies. IntechOpen, (Pharmaceutical Science).
Allbwn ymchwil: Pennod mewn Llyfr/Adroddiad/Trafodion Cynhadledd 鈥� Pennod 鈥� adolygiad gan gymheiriaid
Gweithgareddau
2026
My research was presented as a poster at the Cancer Research Wales 60th Anniversary Research
23 Hyd 2026
Cysylltau:
Invited seminar by CEA Saclay (I2BC- CNRS)-(French Alternative Energies and Atomic Energy Commission)
1 Hyd 2026
Cysylltau:
Meeting the D虏HP Master鈥檚 students : The event fostered scientific exchange and provided students with valuable insights into contemporary biomedical research and career pathways in the field.
1 Hyd 2026
Cysylltau:
Teaching and lecturing MSc students at the School of Pharmacy, Paris-Saclay University
21 Medi 2026
Cysylltau:
10 Medi 2026
Gweithgaredd: Sgwrs wadd (Siaradwr)My academic visit to Paris Saclay University in France was funded through my Taith research mobility award.
30 Awst 2026 鈥� 10 Hyd 2026
Gweithgaredd: Ymweld 芒 sefydliad academaidd allanol (Ymchwilydd Gwadd)16 Gorff 2026
Cysylltau:
24 Meh 2026
Gweithgaredd: Sgwrs wadd (Siaradwr)My academic visit to Florence University was funded through my one鈥憁onth Taith research mobility award, and I am grateful to Florence University for generously extending and supporting the visit for an additional two weeks.
15 Meh 2026 鈥� 30 Gorff 2026
Gweithgaredd: Ymweld 芒 sefydliad academaidd allanol (Ymchwilydd Gwadd)The RSC-BMCS Symposium on Mastering Medicinal Chemistry
13 Maw 2026
Cysylltau:
My academic visit to UCL was supported through the 精东传媒 Fund
12 Maw 2026
Gweithgaredd: Ymweld 芒 sefydliad academaidd allanol (Ymchwilydd Gwadd)27 Chwef 2026
Cysylltau:
Projectau
-
01/05/2026 鈥� 15/05/2028 (Wrthi'n gweithredu)
-
01/02/2026 鈥� 15/02/2027 (Wrthi'n gweithredu)
Blaenorol
To share her research and engage with the global scientific community, she has participated in over 45 international conferences and symposiums across Europe, Japan, the UK, the UAE, Egypt, and Syria.聽 She actively contributes to scholarly publishing as a regular reviewer for leading Q1 journals such as Frontiers in Chemistry, Journal of Drug Delivery Science and Technology, International Journal of Biological Macromolecules, and various MDPI journals. She has been recognized as a trusted reviewer and currently serve on the editorial board of the Archive of Advanced Chemistry Journal, as well as a guest editor for MDPI journals.
Beyond academia, she鈥檚 passionate about making science accessible to younger generations. As a STEM ambassador, she actively supports school outreach initiatives, inspiring future scientists and promoting engagement with the pharmaceutical sciences